Analyst Ratings For Adamis Pharmaceuticals (NASDAQ:ADMP)
Today, B. Riley lowered its price target on Adamis Pharmaceuticals (NASDAQ:ADMP) to per share.
Some recent analyst ratings include
Recent Insider Trading Activity For Adamis Pharmaceuticals (NASDAQ:ADMP)
Adamis Pharmaceuticals (NASDAQ:ADMP) has insider ownership of 12.20% and institutional ownership of 12.42%.
- On 6/2/2016 David J Marguglio, VP, sold 700 with an average share price of $9.00 per share and the total transaction amounting to $6,300.00.
- On 5/16/2016 David J Marguglio, SVP, sold 4,000 with an average share price of $8.08 per share and the total transaction amounting to $32,320.00.
- On 5/9/2016 David J Marguglio, SVP, sold 4,860 with an average share price of $10.00 per share and the total transaction amounting to $48,600.00.
- On 5/4/2016 David J Marguglio, SVP, sold 4,860 with an average share price of $9.17 per share and the total transaction amounting to $44,566.20.
- On 5/3/2016 David J Marguglio, SVP, sold 1,140 with an average share price of $9.00 per share and the total transaction amounting to $10,260.00.
- On 4/14/2016 David J Marguglio, SVP, sold 12,000 with an average share price of $7.52 per share and the total transaction amounting to $90,240.00.
- On 8/14/2015 Robert B Rothermel, Director, bought 7,000 with an average share price of $3.33 per share and the total transaction amounting to $23,310.00.
Recent Trading Activity for Adamis Pharmaceuticals (NASDAQ:ADMP)
Shares of Adamis Pharmaceuticals closed the previous trading session at with 535865 shares trading hands.